ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,754Medicare Part D Prescriptions Filled, Including Refills

Rank: 346 out of 3647

$764K Total Retail Price of All Prescriptions

Rank: 460 out of 3647

630 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 630 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 14,667 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 830 735 1 1
OMEPRAZOLE 718 656 2 3
VITAMIN D2 659 587 3 100
LEVOTHYROXINE SODIUM 659 536 3 5
AMLODIPINE BESYLATE 619 550 5 2
METFORMIN HCL 494 432 6 6
LISINOPRIL 461 412 7 4
METOPROLOL SUCCINATE 316 313 8 18
ZOLPIDEM TARTRATE 313 275 9 14
ALENDRONATE SODIUM 260 234 10 23
ATENOLOL 259 234 11 10
METOPROLOL TARTRATE 258 232 12 7
CRESTOR 253 233 13 19
FENOFIBRATE 250 200 14 50
GLIPIZIDE 246 224 15 41
ALPRAZOLAM 240 206 16 31
LOSARTAN POTASSIUM 224 200 17 11
CARVEDILOL 220 174 18 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 216 177 19 36
DICLOFENAC SODIUM 186 171 20 86
LOSARTAN-HYDROCHLOROTHIAZIDE 184 177 21 48
ATORVASTATIN CALCIUM 177 158 22 13
FUROSEMIDE 170 142 23 8
LOVASTATIN 164 156 24 21
POTASSIUM CHLORIDE 164 131 24 24
HYDROCHLOROTHIAZIDE 160 153 26 9
DIOVAN 142 118 27 40
AZITHROMYCIN 133 117 28 34
NIFEDIPINE ER 130 119 29 67
WARFARIN SODIUM 119 112 30 15
RANITIDINE HCL 117 104 31 29
TEMAZEPAM 117 117 31 47
CLOPIDOGREL 116 102 33 26
DONEPEZIL HCL 116 116 33 30
ALLOPURINOL 113 108 35 37
IBUPROFEN 111 81 36 55
LOVAZA 107 97 37 117
LORAZEPAM 107 94 37 73
PANTOPRAZOLE SODIUM 104 99 39 38
TRAMADOL HCL-ACETAMINOPHEN 103 84 40 152
GABAPENTIN 101 88 41 17
FLUOXETINE HCL 94 91 42 68
ENALAPRIL MALEATE 93 85 43 35
FLUTICASONE PROPIONATE 91 72 44 32
SPIRIVA 90 77 45 93
PLAVIX 90 83 45 39
ISOSORBIDE MONONITRATE ER 88 76 47 56
NAPROXEN 87 68 48 70
PAROXETINE HCL 83 82 49 60
DIOVAN HCT 81 64 50 80
DOXAZOSIN MESYLATE 78 66 51 57
NEXIUM 76 52 52 44
GLYBURIDE-METFORMIN HCL 76 73 R 52 94
SERTRALINE HCL 75 52 54 27
TAMSULOSIN HCL 74 64 55 28
JANUVIA 71 70 56 72
VERAPAMIL ER 71 55 56 99
CLONAZEPAM 65 50 58 146
CLOTRIMAZOLE-BETAMETHASONE 64 56 59 84
SYNTHROID 64 60 59 42
DIGOXIN 63 61 61 51
KLOR-CON 10 61 60 62 106
AMIODARONE HCL 60 51 63 211
CYCLOBENZAPRINE HCL 59 32 R 64 98
FINASTERIDE 58 58 65 66
AMLODIPINE BESYLATE-BENAZEPRIL 58 58 65 74
GLIPIZIDE ER 57 40 67 112
PRAVASTATIN SODIUM 57 56 67 16
ADVAIR DISKUS 57 48 67 52
INSULIN SYRINGE 56 40 70 76
ESCITALOPRAM OXALATE 56 46 70 65
CIPROFLOXACIN HCL 55 48 72 53
DICYCLOMINE HCL 53 53 73 194
TRIAMTERENE-HCTZ 53 46 73 58
AMOXICILLIN 53 36 73 133
NIFEDICAL XL 53 53 73 221
BYSTOLIC 53 50 73 158
BENICAR HCT 52 52 78 165
MECLIZINE HCL 50 50 79 85
FOLIC ACID 50 50 79 95
BENICAR 50 50 79 114
ONGLYZA 50 38 79 238
PENTOXIFYLLINE 50 50 79 180
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 5, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.